Breast Cancer Research and Treatment

, Volume 117, Issue 3, pp 679–681 | Cite as

Absence of the BRCA1 del (exons 9–12) mutation in breast/ovarian cancer families outside of Mexican Hispanics

  • Diana Torres
  • Muhammad U. Rashid
  • Colombian Breast Cancer Study Group (COLBCS)
  • Antje Seidel-Renkert
  • Jeffrey N. Weitzel
  • Ignacio Briceno
  • Ute Hamann
Letter to the Editor

Keywords

BRCA1 Genomic rearrangements Exon 9–12 deletion Ethnic groups 

References

  1. 1.
    Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60(5):1013–1020PubMedGoogle Scholar
  2. 2.
    Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, McGuire C, Neuhausen S (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14(7):1666–1671. doi:10.1158/1055-9965.EPI-05-0072 PubMedCrossRefGoogle Scholar
  3. 3.
    Jara L, Ampuero S, Santibanez E, Seccia L, Rodríguez J, Bustamante M, Martínez V, Catenaccio A, Lay-Son G, Blanco R, Reyes JM (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166(1):36–45. doi:10.1016/j.cancergencyto.2005.08.019 PubMedCrossRefGoogle Scholar
  4. 4.
    Torres D, Rashid MU, Gil F, Umana A, Ramelli G, Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U (2007) High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Res Treat 103(2):225–232. doi:10.1007/s10549-006-9370-1 PubMedCrossRefGoogle Scholar
  5. 5.
    Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119(12):2832–2839. doi:10.1002/ijc.22269 PubMedCrossRefGoogle Scholar
  6. 6.
    Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20(6):413–424. doi:10.1002/humu.10154 PubMedCrossRefGoogle Scholar
  7. 7.
    Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, Lerman C (1997) Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32(1–2):51–62. doi:10.1016/S0738-3991(97)00064-5 PubMedCrossRefGoogle Scholar
  8. 8.
    Hughes C, Lerman C, Lustbader E (1996) Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 40(1):25–35. doi:10.1007/BF01806000 PubMedCrossRefGoogle Scholar
  9. 9.
    Croyle RT, Lerman C (1999) Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 25:59–66PubMedGoogle Scholar
  10. 10.
    Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frénay M, Gilbert B, Maugard C, Bignon YJ, Chevrier A, Rossi A, Fricker JP, Nguyen TD, Demange L, Aurias A, Bensimon A, Stoppa-Lyonnet D (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21(44):6841–6847. doi:10.1038/sj.onc.1205685 PubMedCrossRefGoogle Scholar
  11. 11.
    Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, Houdayer C, Hardouin A, Berthet P, Sobol H, Bourdon V, Muller D, Fricker JP, Capoulade-Metay C, Chompret A, Nogues C, Mazoyer S, Chappuis P, Maillet P, Philippe C, Lortholary A, Gesta P, Bézieau S, Toulas C, Gladieff L, Maugard CM, Provencher DM, Dugast C, Delvincourt C, Nguyen TD, Faivre L, Bonadona V, Frébourg T, Lidereau R, Stoppa-Lyonnet D, Tosi M (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43(9):e49. doi:10.1136/jmg.2005.040212 PubMedCrossRefGoogle Scholar
  12. 12.
    Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68(17):7006–7014. doi:10.1158/0008-5472.CAN-08-0599 PubMedCrossRefGoogle Scholar
  13. 13.
    Ferla R, Calo V, Cascio S, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93–vi98. doi:10.1093/annonc/mdm234 PubMedCrossRefGoogle Scholar
  14. 14.
    Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, Ricker CN, Lowstuter KJ, Blazer KR, Tomlinson G, Scholl T (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16(8):1615–1620. doi:10.1158/1055-9965.EPI-07-0198 PubMedCrossRefGoogle Scholar
  15. 15.
    Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ (1997) German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Genes Chromosomes Cancer 18(2):126–132. doi:10.1002/(SICI)1098-2264(199702)18:2<126:AID-GCC7>3.0.CO;2-4 PubMedCrossRefGoogle Scholar
  16. 16.
    Hamann U, Haner M, Stosiek U, Bastert G, Scott RJ (1997) Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families. J Med Genet 34(11):884–888. doi:10.1136/jmg.34.11.884 PubMedCrossRefGoogle Scholar
  17. 17.
    Hamann U, Liu X, Lange S, Ulmer HU, Benner A, Scott RJ (2002) Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany. J Med Genet 39(3):E12. doi:10.1136/jmg.39.3.e12 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Diana Torres
    • 2
  • Muhammad U. Rashid
    • 1
    • 3
  • Colombian Breast Cancer Study Group (COLBCS)
  • Antje Seidel-Renkert
    • 1
  • Jeffrey N. Weitzel
    • 4
  • Ignacio Briceno
    • 2
  • Ute Hamann
    • 1
  1. 1.Deutsches Krebsforschungszentrum, Research Group Molecular Genetics of Breast CancerHeidelbergGermany
  2. 2.Instituto de Genetica Humana, Pontificia Universidad JaverianaUniversidad de la SabanaBogotaColombia
  3. 3.Shaukat Khanum Memorial Cancer Hospital and Research CentreLahorePakistan
  4. 4.Department of Clinical Cancer GeneticsCity of HopeDuarteUSA

Personalised recommendations